Europe higher premarket on vaccine, recovery hopes9 Oct 2020 08:14
Shares in Europe traded higher in the premarket on Friday amid optimism regarding the development of a vaccine against coronavirus and the economic recovery from the crisis caused by the pandemic. The European Union signed a contract with Johnson & Johnson to ensure access to the potential vaccine, as well as one with Gilead over the supplies of the cure Remdesivir. Meanwhile, the European Central Bank noted the markets showed resilience and remained stable amid the crisis. In the United Kingdom, the Bank of England stressed British banks are "strong enough" to support the economy. The traders in Britain are also waiting for the country's latest reports on the trade balance, industrial production, and gross domestic product (GDP).
The DAX traded 0.16% higher at 8:00 am CET. At the same time, the FTSE 100 rose by 0.27%, and the CAC 40 increased by 0.30%.
The euro grew 0.10% to the dollar to sell for $1.17712 at 8:01 am CET. At the same moment, the pound sterling gained 0.06% against the greenback to exchange hands for $1.29454.
Breaking the News / JR
Happy Friday y’al
Gold .75% better than yesterday’s close currently at $1908.65